Literature DB >> 9612730

High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR.

M Schröter1, H H Feucht, P Schäfer, B Zöllner, R Laufs.   

Abstract

Among patients undergoing maintenance hemodialysis, a high prevalence of hepatitis C virus (HCV) infection can be observed. In a prospective study, sera of 273 patients were examined for the presence of HCV infection by serological tests and by PCR. Thirty-five patients (12.8%) were HCV antibody positive, and in 31 of them HCV RNA could be detected by PCR. Among the 238 seronegative patients HCV infection was detected in 12 cases (5.0%) exclusively by PCR. Only in 1 of these patients seroconversion could be observed within the 18-month follow-up period. These findings demonstrate that in hemodialysis patients PCR is necessary for the diagnosis of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9612730     DOI: 10.1159/000150558

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  13 in total

1.  Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Authors:  Matthias Schröter; Bernhard Zöllner; Peter Schäfer; Andreas Reimer; Matthias Müller; Rainer Laufs; Heinz-Hubert Feucht
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Authors:  M Schröter; S Polywka; B Zöllner; P Schäfer; R Laufs; H H Feucht
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Definition of false-positive reactions in screening for hepatitis C virus antibodies.

Authors:  M Schröter; H H Feucht; P Schäfer; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Authors:  M Schröter; B Zöllner; P Schäfer; R Laufs; H H Feucht
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 5.  Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.

Authors:  Chukwuma Mbaeyi; Nicola D Thompson
Journal:  Semin Dial       Date:  2013-05-31       Impact factor: 3.455

6.  Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.

Authors:  M Schröter; H H Feucht; P Schäfer; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients.

Authors:  G Garinis; N Spanakis; V Theodorou; V Gorgoulis; E Manolis; A Karameris; D Valis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

8.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.

Authors:  Nahum Méndez-Sánchez; Daniel Motola-Kuba; Norberto C Chavez-Tapia; Jesús Bahena; Ricardo Correa-Rotter; Misael Uribe
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Authors:  S Polywka; M Schröter; H H Feucht; B Zöllner; R Laufs
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.